Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, GOLDMAN SACHS GROUP INC insiders sold a net $34.8M of stock across 362 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Nobody has filed for crossing 5%. That is a fact, not missing data.
GS planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
LESLIE ERICKA T
Filed 2026-10-22
$904.7K
LESLIE ERICKA T
Filed 2026-08-28
$624.5K
LESLIE ERICKA T
Filed 2026-08-04
$179.7K
Ruemmler Kathryn H.
Filed 2026-07-23
$3.9M
LESLIE ERICKA T
Filed 2026-07-15
$285.0K
GS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Goldman Sachs Global Managed Beta Fund
$1.2B position · as of 2026-05-31
24.6%
iShares U.S. Broker-Dealers & Securities Exchanges ETF
$274.2M position · as of 2026-06-30
20.6%
Goldman Sachs Dynamic Global Equity Fund
$80.4M position · as of 2026-06-30
16.5%
Goldman Sachs Growth Allocation Fund
$201.1M position · as of 2026-06-30
16.0%
Goldman Sachs Conservative Allocation Fund
$81.0M position · as of 2026-06-30
12.7%
3EDGE Dynamic Fixed Income ETF
$58.4M position · as of 2026-06-30
12.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Government contracts
Award ceilings over the contract's life, subsidiaries included.
Not annual revenue (USASpending.gov).
Department Of The Treasury
SILVER RAW MATERIAL MINT MAC SILVER BULLION · 2026-07-21
$34.5M
Federal awards ≥ $25M in the last 90 days, matched via the SAM.gov parent registry
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
The Goldman Sachs Group, Inc. Political Action Committee
Cycle 2026 · $783K spent
$973.0K
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$118.9M
$309.8M
$45.9M
+275%
+103%
2024
$31.3M
$120.0M
$20.9M
+140%
+76%
2023
$27.0M
$12.7M
$18.1M
+58%
+35%
2022
$32.2M
$27.3M
$22.8M
+36%
+21%
2021
$40.7M
$97.4M
$21.5M
+48%
+35%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $34.8M sold by insiders over 180 days, 1,839 funds added last quarter, 5 House member(s) bought in 12 months, disclosed weeks after the trade, $1.7M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM GS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM GS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
-$41.5B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM GS
FY Dec 2025
-$47.2B
FY Dec 2024
-$15.3B
FY Dec 2023
-$14.9B
FY Dec 2022
$5.0B
FY Dec 2021
$1.6B
Jun 2026
$5.6B
Mar 2026
-$32.4B
Dec 2025
-$16.8B
Sep 2025
$2.1B
Jun 2025
$5.2B
Mar 2025
-$37.7B
Dec 2024
$46.2B
Sep 2024
-$38.5B
At each fiscal year end
Single quarter
Debt to equity
2.45x
long-term 2019-09-30 (82 months older than the period end) plus current 2025-09-30 (9 months older than the period end); equity 2026-06-30
Debt to equity GS
FY Dec 2025
2.41x
FY Dec 2024
2.45x
FY Dec 2023
2.61x
FY Dec 2022
2.47x
FY Dec 2021
2.08x
Jun 2026
2.45x
Mar 2026
2.45x
Dec 2025
2.41x
Sep 2025
2.42x
Jun 2025
2.40x
Mar 2025
2.41x
Dec 2024
2.45x
Sep 2024
2.51x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-0.13x
TTM operating cash flow over long-term 2019-09-30 (82 months older than the period end) plus current 2025-09-30 (9 months older than the period end)
Cash flow to debt GS
FY Dec 2025
-0.15x
FY Dec 2024
-0.04x
FY Dec 2023
-0.04x
FY Dec 2022
0.03x
FY Dec 2021
0.03x
Jun 2026
-0.13x
Mar 2026
-0.13x
Dec 2025
-0.15x
Sep 2025
0.06x
Jun 2025
-0.08x
Mar 2025
-0.07x
Dec 2024
-0.04x
Sep 2024
-0.29x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+17.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity GS
FY Dec 2025
+13.9%
FY Dec 2024
+12.0%
FY Dec 2023
+7.3%
FY Dec 2022
+9.9%
FY Dec 2021
+21.0%
Jun 2026
+17.0%
Mar 2026
+14.6%
Dec 2025
+13.9%
Sep 2025
+13.6%
Jun 2025
+12.8%
Mar 2025
+12.3%
Dec 2024
+12.0%
Sep 2024
+10.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets GS
FY Dec 2025
+1.0%
FY Dec 2024
+0.9%
FY Dec 2023
+0.6%
FY Dec 2022
+0.8%
FY Dec 2021
+1.6%
Jun 2026
+1.1%
Mar 2026
+0.9%
Dec 2025
+1.0%
Sep 2025
+0.9%
Jun 2025
+0.9%
Mar 2025
+0.9%
Dec 2024
+0.9%
Sep 2024
+0.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital GS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed GS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
13.52x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing GS
FY Dec 2025
17.14x
FY Dec 2024
14.14x
FY Dec 2023
16.90x
FY Dec 2022
11.41x
FY Dec 2021
6.44x
Jun 2026
15.61x
Mar 2026
15.47x
Dec 2025
17.14x
Sep 2025
16.19x
Jun 2025
15.61x
Mar 2025
12.69x
Dec 2024
14.14x
Sep 2024
14.53x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$368.8B
market value at close 2026-10-23 on 2026-07-17 shares, plus long-term 2019-09-30 (82 months older than the period end) plus current 2025-09-30 (9 months older than the period end), minus cash 2026-06-30
Enterprise value GS
FY Dec 2025
$400.5B
FY Dec 2024
$296.1B
FY Dec 2023
$188.9B
FY Dec 2022
$164.1B
FY Dec 2021
$95.8B
Jun 2026
$412.2B
Mar 2026
$372.6B
Dec 2025
$400.5B
Sep 2025
$372.6B
Jun 2025
$361.9B
Mar 2025
$302.8B
Dec 2024
$296.1B
Sep 2024
$305.8B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-16.3%
TTM free cash flow over market value at close 2026-10-23
FCF yield GS
FY Dec 2025
-17.9%
FY Dec 2024
-8.5%
FY Dec 2023
-11.8%
FY Dec 2022
+4.3%
FY Dec 2021
+1.3%
Jun 2026
-13.9%
Mar 2026
-16.7%
Dec 2025
-17.9%
Sep 2025
+6.5%
Jun 2025
-11.5%
Mar 2025
-14.4%
Dec 2024
-8.5%
Sep 2024
-57.8%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.32x
P/E over trailing EPS growth of 43%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing GS
FY Dec 2025
0.64x
FY Dec 2024
0.18x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
0.05x
Jun 2026
0.36x
Mar 2026
0.57x
Dec 2025
0.64x
Sep 2025
0.37x
Jun 2025
0.34x
Mar 2025
0.19x
Dec 2024
0.18x
Sep 2024
0.22x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
GS ranks highest on institutional and government (72nd percentile) and profitability (61st), and lowest on insider conviction (3rd), among Financial Services peers.
Profitability
61
Inputs
Return on equity+17.0% · 68 pct, sector of 205
Return on assets+1.1% · 54 pct, sector of 266
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
25
Inputs
Debt to equity2.45x · 14 pct, sector of 181
Cash flow to debt-0.13x · 35 pct, sector of 141
Insider conviction
3
Inputs
Net Form 4 buying (codes P and S), 180d-$34.8M · 6 pct, sector of 161
Insider buyers, 180d0 · 0 pct, sector of 165
Institutional and government
72
Inputs
Funds adding, latest quarter1,839 · 100 pct, sector of 278
Congress net buyers, 365d0 · 37 pct, sector of 31
Federal contracts, 180d$34.5M · 53 pct, universe of 69
Lobbying spend, 4 quarters$5.8M · 97 pct, sector of 40
Risk and compliance
58
Inputs
Short interest, % of float+2.3% · 58 pct, sector of 390
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Growth, US patents
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
GS filings, in plain words
Are Goldman Sachs insiders buying or selling GS?
In the 180 days to 2026-10-27, Goldman Sachs insiders were net sellers, a net $34.8M across purchases and sales reported on Form 4, by 5 sellers.
Have members of Congress traded GS?
Yes. In the year to 2026-10-27, 5 House members disclosed buying GS and 5 House members disclosed selling it; the latest on record is a sale by Maria Elvira Salazar dated 2026-09-24.
Are there planned insider sales of GS?
Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $1.7M of stock; the latest, by LESLIE ERICKA T, was filed 2026-10-22.
Read the full summary
In the 180 days to 2026-10-27, Goldman Sachs insiders were net sellers of GS, a net $34.8M across purchases and sales reported on Form 4 by 5 sellers. None of the 28 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-27, 5 members of Congress disclosed buying GS and 5 members disclosed selling it; the latest on record is a sale by Maria Elvira Salazar dated 2026-09-24. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $1.7M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.